Abstract
Ovarian endometriosis can transform into malignant tumors. The author retrospectively examined HE slides of 112 serous tumors and 75 mucinous tumors for the existence of ovarian endometriosis. When endometriosis is present within the tumors, the term “endometriosis-derived tumor” was applied. When endometriosis is recognized adjacent to the tumor, the term “endometriosis-associated tumor” was used. Of the 112 serous tumors (46 benign, 18 borderline, and 50 malignant), 4 (3.5%) (2 benign and 2 malignant) were endometriosis-associated tumors. None was endometriosis-derived tumor. Of the 75 mucinous tumors (30 benign, 26 borderline, and 19 malignant), 4 (5%) (1 borderline and 3 benign) were endometriosis-associated tumors. No tumors showed endometriosis-derived tumors. The data suggest that endometriosis does not transform into serous and mucous tumors. The author felt the limitation of retrospective survey, because the limited numbers of slides (5 to 15) were obtained from each tumor. The author also felt that endometriosis can be difficult to discern because of degenerative changes and other similar lesions such as fallopian tube, fimbria, inclusion cysts, rete ovarii, paraovarian cyst, and Müllerian ducts remnants. Prospective study using whole ovarian examination is required.
Keywords: Ovary tumor, endometriosis, ovary serous tumor, ovary mucinous tumor, endometriosis-derived tumor
Introduction
It is well recognized that malignant transformation can occur in ovarian endometriosis [1, 2]. Nishida et al [2] reported that 18 cases of atypical endometriosis and one case of ovarian carcinoma were recognized in the 147 cases of the ovarian endometriosis; thus the incidence of malignancy in ovarian endometriosis is 0.7%. Kontoravdis et al [3] reported that there were 13 (2%) cases of ovarian malignancy among 667 cases of endometriosis. Two of the most common malignant tumors of such a situation were clear cell adenocarcinoma and endometrioid adenocarcinoma [3]. Stern et al [4] reported that ovarian malignancies were associated with endometriosis in 3.2 - 10% of cases, and these percentages varied among observers.
The histologically types of endometriosis-associated malignancy were mostly clear cell adenocarcinoma and endometrioid adenocarcinoma, and serous and mucous tumors are infrequently associated with endometriosis [4-9].
Yoshikawa et al [4] reported that malignancies in endometriosis are clear cell (39.2%), endometrioid (21.2%), serous (3.3%), and mucinous type (3.0%). Vercelli et al [10] reported that among the endometriosis-associated malignant, serous tumor accounted for 3.6%, mucinous tumor 5.6%, endometrioid tumor 26.3%, clear cell tumor 21%, and mixed tumor 22%.
The author reviewed 187 serous and mucinous tumors for the existence of endometriosis.
Materials and methods
The author reviewed HE-slides (1 - 11 slides) of 112 cases of serous tumors and 75 cases of mucinous tumors of the ovary in the last 12 years of our pathology laboratory for the presence of endometriosis. Mixed tumors were present in 11 cases, and they were labeled as serous, mucinous, or other tumors depending on the majority histology. In the present study, when endometriosis was present within the tumors, the term “endometriosis-derived tumor” was applied. When endometriosis was recognized adjacent to the tumor, the term “endometriosis-associated tumor” was used.
Results
Of the 112 serous tumors, 46 were benign, 18 were borderline, and 50 were malignant. Of the 112 cases, 4 cases (3.5%) (2 benign and 2 malignant) were endometriosis-associated tumors (Figure 1). None was endometriosis-derived tumor. Of the 75 mucinous tumors, 30 were benign, 26 were borderline, and 19 were malignant), 4 cases (5%) (1 borderline and 3 benign) were endometriosis associated tumors (Figure 2). None was endometriosis-derived tumor.
Figure 1.
A case of endometriosis-associated serous papillary adenocarcinoma. A. Macroscopic features. The carcinoma element was not obvious because it was examined by frozen sections. B. The serous adenocarcinoma element. HE, xioo. C. Endometriosis was present in the vicinity of the serous adenocarcinoma. HE.
Figure 2.
A case of endometriosis-associated mucinous cystadenoma. A. macroscopic features. B. The endometriosis (chocolate cyst) (lower) is seen in the vicinity of the mucinous cystadenoma (upper). HE, x40. C. The mucinous cystadenoma area. HE.
That is, there were 8 cases of tumors with endometriosis adjacent to the tumors. However, there were no cases in which endometriosis was present within the tumors. Of course, there were no merges between tumor epithelium and endometriosis epithelium.
Discussion
In the present study, the authors identified no cases of endometriosis-derived serous and mucous tumors in the 187 cases. This strongly suggests that endometriosis does not transform into serous and mucous tumors of the ovary. In the present study, there were 4 cases of endometriosis-associated tumors. However, in these tumors, the tumors and endometriosis were located separately, and there were no merges between endometriosis epithelium and tumor epithelium. This suggests that the endometriosis-associated tumors were simply coincidental.
Previous studies on the frequency of endometriosis in serous and mucous tumor in about 5% [4, 10, 11]. However, the previous studies have not demonstrated the direct transition between endometriosis epithelium and tumor epithelium.
During the review, the author felt that endometriosis is difficult to diagnose. Endometriosis is defined as heterotopic presence of endometrium (endometrial epithelium and endometrial stroma). However, these endometrial elements are frequently desquamated, resulting in the so-called “chocolate cysts”. In addition, the endometrial stroma is occasionally absent in endometriosis. The presence of tall columnar epithelium without endometrial stroma is recognized in serous tumors, mucous tumors, and other tumors, as well as in endosalpingiosis, rete ovarii, fimbria, paraovarian cyst, inclusion cyst, and Müllerian duct remnants. In the present study, the endometriosis-like tall columnar epithelium without endometrial stroma was recognized in several cases, but these cases cannot be labeled as endometriosis. The cilia of fallopian tube associated cysts do not exclude endometriosis because endometriosis may show ciliated metaplasia [12]. In any way, the criteria of endometriosis in so-called endometriosis-associated ovarian tumors are not unified. It is mandatory that the presence of endometrial epithelium and endometrial stroma is essential for the diagnosis of endometriosis.
References
- 1.Scully RE, Richardson GS, Barlow JF. The development of malignancy in endometriosis. Clin Obstet Gynecol. 1966;9:384–411. doi: 10.1097/00003081-196606000-00008. [DOI] [PubMed] [Google Scholar]
- 2.Nishida M, Watanabe K, Sato N, Ichikawa Y. Malignant transformation of ovarian endometroosis. Gynecol Obstet Invest. 2000;50:18–25. doi: 10.1159/000052874. [DOI] [PubMed] [Google Scholar]
- 3.Kontoravdis A, Augoulea A, Lambrinoudaki I, Christodoulakos G, Tzorztiotis D, Grammatikakis I, Kontravdis N, Crestsas G. Ovarian andometrosis associated with ovarian cancer and endometrial-endocervical polyps. J Obstet Gynecol Res. 2007;33:294–298. doi: 10.1111/j.1447-0756.2007.00527.x. [DOI] [PubMed] [Google Scholar]
- 4.Stern RC, Dash R, Bentley RC, Snyder MJ, Haney AF, Robboy SJ. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol. 2001;20:133–139. doi: 10.1097/00004347-200104000-00004. [DOI] [PubMed] [Google Scholar]
- 5.Yoshikawa H, Jimbo H, Okada S, Matsumoto K, Onda T, Yasugi T, Taketani Y. Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest. 2000;50:11–17. doi: 10.1159/000052873. [DOI] [PubMed] [Google Scholar]
- 6.Valezuela P, Ramos P, Redondo S, Cabrera Y, Alvarez I, Ruiz A. Endometrioid adenocarcinoma of the ovary and endometriosis. Eur J Obstet Gynecol Reprod Biol. 2007;134:83–86. doi: 10.1016/j.ejogrb.2006.06.008. [DOI] [PubMed] [Google Scholar]
- 7.DePriest PD, Banks ER, Powell DE, van Nagell JR, Gallion HH, Puls LE, Hunter JE, Kryscio RJ, Royalty MB. Endometrioid adenocarcinoma of the ovary and endometriosis: the association in postmenopausal women. Gynecol Oncol. 1992;47:71–75. doi: 10.1016/0090-8258(92)90079-x. [DOI] [PubMed] [Google Scholar]
- 8.Sainz de la Cuesta R, Eichhorn JH, Rice LW, Fuller AF, Nikrui N, Goff BA. Histological transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol. 1996;60:238–244. doi: 10.1006/gyno.1996.0032. [DOI] [PubMed] [Google Scholar]
- 9.Ogawa S, Kaku T, Amada S, Kobayashi H, Hira-kawa T, Ariyoshi K, Kamura T, Nakano H. Ovarian endometoriosis associated with ovarian carcinoma: a clinicopathologic and immunohistochemical study. Gynecol Oncol. 2000;77:298–304. doi: 10.1006/gyno.2000.5765. [DOI] [PubMed] [Google Scholar]
- 10.Vercellini P, Parazzini F, Bolis G, Carinell S, Dindelli M, Vendola N, Luchini L, Crosignani PG. Endometriosis and ovarian cancer. Am J Obstet Gynecol. 1993;169:181–182. doi: 10.1016/0002-9378(93)90159-g. [DOI] [PubMed] [Google Scholar]
- 11.Jimbo H, Yoshikawa H, Onda T, Yasugi T, Sakamoto A, Taketani Y. Prevalence of ovarian endometriosis in epithelial ovarian cancer. Int J Gynecol Pathol. 1997;59:245–25. doi: 10.1016/s0020-7292(97)00238-5. [DOI] [PubMed] [Google Scholar]
- 12.Fukunaga M, Ushigome S. Epithelial metaplastic changes in ovarian endometriosis. Mod Pathol. 1998;11:784–788. [PubMed] [Google Scholar]


